trial

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

NCTId NCT00946985
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Terminated
Enrollment 163 (actual)
Sponsored by Ortho-McNeil Janssen Scientific Affairs, LLC
Primary completion 2010-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Terminated
Enrollment
163 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2009-06
Primary completion
2010-03
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
PaliperidoneRisperidone

Sponsors

Ortho-McNeil Janssen Scientific Affairs, LLCLead Sponsor

Sites

0 total

Facts & assertions

4 sourced
Enrollment
163
Phase
PHASE4
Primary Completion Date
2010-03
Status
TERMINATED
relationships
The graph out of here
drug
Paliperidone
drug
Risperidone
drug
lead_sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC
company
indication
Schizophrenia
indication
Schizophrenia
indication